Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
Collaboration leverages Astex’s industry-leading, fragment-based drug discovery capability to target a key cell-cycle-dependent regulator in breast cancer Astex to receive an upfront and potential milestone payments, totalling more than $490 million as …